Global Trypsin Market Size, Share, and COVID-19 Impact Analysis, By Type (Porcine and Bovine), By Application (Biotechnology and Pharmaceutical Industry, Food Industry, Cosmetics and Personal Care, Waste Treatment, and Others), By End-User (Research, Diagnostic, and Industrial use), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare

RELEASE DATE Jun 2024
REPORT ID SI4717
PAGES 230
REPORT FORMAT PathSoft

Global Trypsin Market Insights Forecasts to 2033

  • The Global Trypsin Market Size was Valued at USD 90.8 Million in 2023
  • The Market Size is Growing at a CAGR of 5.26% from 2023 to 2033
  • The Worldwide Trypsin Market Size is Expected to Reach USD 151.6 Million by 2033
  • Asia Pacific is Expected to Grow the fastest during the forecast period.

 

Global Trypsin Market

Get more details on this report -

Request Free Sample PDF

 

The Global Trypsin Market Size is Anticipated to Exceed USD 151.6 Million by 2033, Growing at a CAGR of 5.26% from 2023 to 2033.

 

Market Overview

The pancreatic enzyme which helps in protein digestion is called trypsin. Proteins in the small intestine are broken down by trypsin. It is also known as a proteinase or proteolytic enzyme. The pancreas produces the inactive form of trypsin, known as trypsinogen, which is transformed into the active form of trypsin upon entering the small intestine. The dietary protein is broken down into amino acids and peptides by trypsin and the other two proteinases, pepsin and chymotrypsin. These amino acids are necessary for the body to produce hormones, build muscle, and perform different functions. Trypsin's unique ability to hydrolyze proteins during digestion has made it an essential resource for research and development in the food, pharmaceutical, and environmental industries. It is a raw material for clinical surgery and internal medicine treatments of endocrine disorders. In the food, beverage, and pharmaceutical industries, the usage of enzyme catalysts in commercial operations has increased. These enzymes are very effective in the food, pharmaceutical, and feed industries because they improve waste reduction. Additionally, TRYPSIN VI, the best source of trypsin, has been used in nutraceuticals for human and veterinary purposes as a digestive supplement and anti-inflammatory therapy. Innovative products that make use of particular technologies are available on the trypsin market, catering to the changing needs and preferences of consumers.

 

Report Coverage

This research report categorizes the global trypsin market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global trypsin market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global trypsin market.

 

Global Trypsin Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023 :USD 90.8 Million
Forecast Period:2023 – 2033
Forecast Period CAGR 2023 – 2033 :5.26%
023 – 2033 Value Projection:USD 151.6 Million
Historical Data for:2019-2022
No. of Pages:230
Tables, Charts & Figures:110
Segments covered:By Type, By Application, By End-User, By Region
Companies covered:: Promega Corporation, Merck KgaA, Geno Technology Inc, Thermo Fisher Scientific Inc, SignalChem Biotech Inc, Takara Bio Inc, Creative Enzymes, ProteoChem, Waters Corporation, Bioseutica, Bovogen Biologicals Pty Ltd, BBI Solutions, Sun Pharma, Sartorius AG, Others
Pitfalls & Challenges:Covid-19 Impact, Challenge, Future,Growth and Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

Trypsin is becoming more widely used in a variety of industries, including medicines, food science research, detergents, and leather-bating. This is expected to power source market expansion, which is also being further fueled by an increased focus on drug discovery and development. In reaction to growing customer demand for environmentally conscious products, the trypsin market is increasingly focused on sustainability activities, such as lowering carbon footprint, recycling programs, and using eco-friendly materials. Throughout the projected time, trypsin development and applications, along with an increase in product releases, are going to drive growth in the market.

 

Restraining Factors

Trypsin is a protein that can undergo autolysis or auto-digestion, which is the process of breaking down cells by an internal enzymatic activity. Moreover, there is no ensure that all of the protein will be completely digested when using trypsin, which is one of the main factors that are expected to hinder the growth of the trypsin market.

 

Market Segmentation

The global trypsin market share is classified into type, application, and end-user.

 

  • The bovine segment dominates the market with the largest market share through the forecast period.

Based on the type, the global trypsin market is categorized into porcine and bovine. Among these, the bovine segment dominates the market with the largest market share through the forecast period. Bovine trypsins are a specific separating function responsible for a wide range of uses in different industries. the benefits of such factors, compared to other proteases, bovine trypsin is reasonably priced and easily accessible. While research facilities like Sisco Research Laboratories use bovine trypsin for cell growth, animal-derived trypsin is used for vaccine production.

 

  • The biotechnology and pharmaceutical industry segment is anticipated to grow at the fastest CAGR growth through the forecast period.

Based on the application, the global trypsin market is categorized into the biotechnology and pharmaceutical industry, food industry, cosmetics and personal care, waste treatment, and others. Among these, the biotechnology and pharmaceutical industry segment is anticipated to grow at the fastest CAGR growth through the forecast period. The one of particularly strongly creative sectors of the economy in many nations is the biotechnology and pharmaceutical industry, where businesses are spending to create premium, naturally occurring enzymes and proteins. Nutraceutical sources and baby formulae can be developed using diagnostic media and functional food additives. Pharma businesses are more use enzymes when trypsin has a variety of applications, which will accelerate the growth of the market.

 

  • The industrial use segment accounted for the largest revenue share through the forecast period.

Based on the end-user, the global trypsin market is categorized into research, diagnostic, and industrial use. Among these, the industrial use segment accounted for the largest revenue share through the forecast period. The reason is related to the increasing usage of trypsin in the food and pharmaceutical industries, as well as in detergents and leather bating. Trypsin is utilized in detergents to degrade protein-based stains such as those from eggs, blood, and other organic materials. It is used to enhance the functional qualities of food proteins, such as emulsification, foaming, solubility, and gelling, but its usage in detergents has been restricted because of worries about its safety and potential effects on the environment.  

 

Regional Segment Analysis of the Global Trypsin Market

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the global trypsin market over the predicted timeframe.

 

Global Trypsin Market

Get more details on this report -

Request Free Sample PDF

 

North America is anticipated to hold the largest share of the global trypsin market over the predicted timeframe. Trypsin is more in demand in the diagnostic field due to the rise in pancreatitis, cystic fibrosis, and cancer cases in the region. For instance, the American Lung Association reports that in November 2022, there were around 30,000 cases of cystic fibrosis in the United States and that 1 in 30 people are carriers of the disease. In addition, because trypsin plays a tumor-suppressive role in the course of cancer, enzyme therapy shows promising outcomes in growth inhibition of tumor cells with metastatic potential. These elements are expected to drive the trypsin industry. Additionally, several alliances and partnerships between businesses have supported in the expansion of the regional market.  

 

Asia Pacific is expected to grow at the fastest CAGR growth of the global trypsin market during the forecast period. The Western Pacific and South Asia regions showed the highest prevalence. Because of poverty and inadequate infrastructure, almost 90% of deaths occur in low- and middle-income nations. There hasn't been any advancement in the treatment of burns, and as germs have grown more resistant, burn cases have been trickier to handle. As a result, treatments augment oral hydrolytic enzymes, primarily trypsin, to decrease inflammation. The need for trypsin in this area may rise as a result of these considerations.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global trypsin market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Promega Corporation
  • Merck KgaA
  • Geno Technology Inc
  • Thermo Fisher Scientific Inc
  • SignalChem Biotech Inc
  • Takara Bio Inc
  • Creative Enzymes
  • ProteoChem
  • Waters Corporation
  • Bioseutica
  • Bovogen Biologicals Pty Ltd
  • BBI Solutions
  • Sun Pharma
  • Sartorius AG
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Recent Developments

  • In March 2023, Water Corp introduced its RapiZyme Trypsin, It was found out that this chemically improved recombinant new trypsin provides top standard reliability while decreasing the digestion time down from over three hours to a mere 30 minutes

 

  • In January 2023, Sun Pharma India completed the acquisition and buyout of Disperzyme and Phlogam brands from Aksigen, these are the first combinations of enzyme-bioflavonoid that have completed a scientific study and got DCGI approval in India and are intended for patients who are undergoing minor surgery for controlling the inflammatory process

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global trypsin market based on the below-mentioned segments: 

 

Global Trypsin Market, By Type

  • Porcine
  • Bovine

 

Global Trypsin Market, By Application

  • Biotechnology and Pharmaceutical Industry
  • Food Industry
  • Cosmetics and Personal Care
  • Waste Treatment
  • Others

 

Global Trypsin Market, By End User

  • Research
  • Diagnostic
  • Industrial use

 

Global Trypsin Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions (FAQ)

  • 1. Which are the key companies that are currently operating within the market?
    Promega Corporation, Merck KgaA, Geno Technology Inc., USA, Thermo Fisher Scientific Inc., SignalChem Biotech Inc., Takara Bio Inc., Creative Enzymes, ProteoChem, Waters Corporation, Bioseutica, Bovogen Biologicals Pty Ltd., BBI Solutions, Sun Pharma, Sartorius AG and others.
  • 2. What is the size of the global Trypsin market?
    The Global Trypsin Market Size is Expected to Grow from USD 90.8 Million in 2023 to USD 151.6 Million by 2033, at a CAGR of 5.26% during the forecast period 2023-2033.
  • 3. Which region is holding the largest share of the market?
    North America is anticipated to hold the largest share of the global trypsin market over the predicted timeframe.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies